Antiemetic Effect of the Addition of Ondansetron to the Morphine Solution in Patient-Controlled Analgesia (PCA)

NCT ID: NCT00199329

Last Updated: 2018-03-21

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 160 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2005-01-31

Brief Summary

PCA morphine always introduces nausea and vomiting during the postoperative period. Ondansetron can reduce PONV (postoperative nausea vomiting). We, the researchers at Khon Kaen University, are trying to add ondansetron in PCA morphine. Patients receive a small dose of ondansetron when they request morphine.

Conditions

Postoperative Nausea and Vomiting

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: QUADRUPLE

Interventions

ondansetron adding in PCA

Intervention Type: DRUG

Eligibility Criteria

Inclusion Criteria

• Age between 15-60 years old

Exclusion Criteria

• History of motion sickness, smoking

• Minimum Eligible Age: 15 Years
• Maximum Eligible Age: 60 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Khon Kaen University

OTHER

Sponsor Role: lead

Principal Investigators

Polpun Boonmak, MD

Role: STUDY_DIRECTOR

lecturer in Khon Kaen University

Locations

Khon Kaen university, Srinagarind Hospital

Muang, Changwat Khon Kaen, Thailand

Countries

Thailand

Other Identifiers

I48027

Identifier Type: -

Identifier Source: org_study_id